In another study by Taylor et al. it was found that SSX1, SSX2, SSX4, and SSX5 were all coexpressed in 20% of patients with multiple myeloma (MM), and this coexpression was found to correlate with adverse prognosis and reduced survival (P = .0006) [86]. This evidence concerns the gene SSX2 and Miyoshi myopathy.